-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $73

Benzinga·07/31/2026 21:42:04
语音播报
UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $67 to $73.